Strategies for controlled delivery of growth factors and cells for bone regeneration.

The controlled delivery of growth factors and cells within biomaterial carriers can enhance and accelerate functional bone formation. The carrier system can be designed with pre-programmed release kinetics to deliver bioactive molecules in a localized, spatiotemporal manner most similar to the natural wound healing process. The carrier can also act as an extracellular matrix-mimicking substrate for promoting osteoprogenitor cellular infiltration and proliferation for integrative tissue repair. This review discusses the role of various regenerative factors involved in bone healing and their appropriate combinations with different delivery systems for augmenting bone regeneration. The general requirements of protein, cell and gene therapy are described, with elaboration on how the selection of materials, configurations and processing affects growth factor and cell delivery and regenerative efficacy in both in vitro and in vivo applications for bone tissue engineering.

[1]  P. Layrolle,et al.  Surface treatments of titanium dental implants for rapid osseointegration. , 2007, Dental materials : official publication of the Academy of Dental Materials.

[2]  M. Kurabayashi,et al.  Notch Signaling Induces Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells: Role of Msx2 Gene Induction via Notch-RBP-Jk Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Ulrich Joos,et al.  VEGF-activated angiogenesis during bone regeneration. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[4]  R. Gurny,et al.  The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[5]  T. Clemens,et al.  Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  G. Im,et al.  Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells. , 2011, Biomaterials.

[7]  Bin Wang,et al.  Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. , 2007, Biomaterials.

[8]  E. Deutsch.  The use of stem cell synthesized extracellular matrix for bone repair , 2009 .

[9]  P. Kasten,et al.  The effect of platelet-rich plasma on healing in critical-size long-bone defects. , 2008, Biomaterials.

[10]  Chi-Hwa Wang,et al.  Optimized bone regeneration based on sustained release from three‐dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP‐2 , 2008, Biotechnology and bioengineering.

[11]  David L. Kaplan,et al.  Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[12]  Eva García,et al.  Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. , 2010, Tissue engineering. Part A.

[13]  K. Mustafa,et al.  Endothelial cells influence the osteogenic potential of bone marrow stromal cells , 2009, Biomedical engineering online.

[14]  L. Bonewald,et al.  Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering , 2009, Journal of tissue engineering and regenerative medicine.

[15]  R. Guldberg,et al.  Inducible regulation of Runx2-stimulated osteogenesis , 2006, Gene Therapy.

[16]  Eben Alsberg,et al.  Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.

[17]  H. Redmond,et al.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Bryant,et al.  Thermoresponsive, in situ cross-linkable hydrogels based on N-isopropylacrylamide: fabrication, characterization and mesenchymal stem cell encapsulation. , 2011, Acta biomaterialia.

[19]  David L Kaplan,et al.  Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Keun-Hong Park,et al.  The use of injectable, thermosensitive poly(organophosphazene)-RGD conjugates for the enhancement of mesenchymal stem cell osteogenic differentiation. , 2009, Biomaterials.

[21]  Tien-Min G. Chu,et al.  Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2. , 2007, Biomaterials.

[22]  Fei Yang,et al.  An injectable scaffold: rhBMP-2-loaded poly(lactide-co-glycolide)/hydroxyapatite composite microspheres. , 2010, Acta biomaterialia.

[23]  Michael J Yaszemski,et al.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.

[24]  Bin Chen,et al.  The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Hideki Yoshikawa,et al.  Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. , 2005, Biomaterials.

[26]  K. Neoh,et al.  Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. , 2009, Tissue engineering. Part A.

[27]  R. Carano,et al.  Angiogenesis and bone repair. , 2003, Drug discovery today.

[28]  A Tampieri,et al.  A novel route in bone tissue engineering: magnetic biomimetic scaffolds. , 2010, Acta biomaterialia.

[29]  Hyun D Kim,et al.  Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. , 2002, Journal of biomedical materials research.

[30]  Jennifer L. Moreau,et al.  Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold. , 2009, Biomaterials.

[31]  Johnny Huard,et al.  VEGF Improves, Whereas sFlt1 Inhibits, BMP2‐Induced Bone Formation and Bone Healing Through Modulation of Angiogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  M. Morra,et al.  Surface engineering of titanium by collagen immobilization. Surface characterization and in vitro and in vivo studies. , 2003, Biomaterials.

[33]  G. C. Chan,et al.  Mesenchymal stem cell-encapsulated collagen microspheres for bone tissue engineering. , 2010, Tissue engineering. Part C, Methods.

[34]  Antonios G Mikos,et al.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.

[35]  Paula T Hammond,et al.  Tunable dual growth factor delivery from polyelectrolyte multilayer films. , 2011, Biomaterials.

[36]  Cato T. Laurencin,et al.  Bone-Graft Substitutes: Facts, Fictions, and Applications , 2001, The Journal of bone and joint surgery. American volume.

[37]  E. Hunziker,et al.  BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. , 2005, Bone.

[38]  Sha Huang,et al.  Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. , 2006, International journal of pharmaceutics.

[39]  Robert Gurny,et al.  Novel thermosensitive chitosan hydrogels: in vivo evaluation. , 2009, Journal of biomedical materials research. Part A.

[40]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[42]  F K Kasper,et al.  Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. , 2010, Acta biomaterialia.

[43]  Yasuhiko Tabata,et al.  Regenerative inductive therapy based on DDS technology of protein and gene , 2006, Journal of drug targeting.

[44]  S. Bidic,et al.  rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. , 2006, The Journal of bone and joint surgery. American volume.

[45]  Casey K Chan,et al.  Cell therapy for bone regeneration--bench to bedside. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[46]  U. Ripamonti.  Soluble osteogenic molecular signals and the induction of bone formation. , 2006, Biomaterials.

[47]  Seok-Jung Kim,et al.  A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast(Ossron™) injection to treat fractures , 2009, BMC Musculoskeletal Disorders.

[48]  A. Goepferich,et al.  Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. , 2009, Journal of biomedical materials research. Part A.

[49]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[50]  Ximeng Sun,et al.  Inorganic–organic hybrid alginate beads with LCST near human body temperature for sustained dual‐sensitive drug delivery , 2008 .

[51]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[52]  Johnny Huard,et al.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.

[53]  J. Tao,et al.  Induced Endothelial Cells Enhance Osteogenesis and Vascularization of Mesenchymal Stem Cells , 2009, Cells Tissues Organs.

[54]  K. Nguyen,et al.  A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[55]  J. Hollinger,et al.  A Bone Regeneration Study: Transforming Growth Factor‐β1 and Its Delivery , 1996 .

[56]  Rui L Reis,et al.  Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. , 2009, Biomaterials.

[57]  Daocheng Wu,et al.  Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement , 2008, Journal of materials science. Materials in medicine.

[58]  Ann-Christine Albertsson,et al.  A strategy for the covalent functionalization of resorbable polymers with heparin and osteoinductive growth factor. , 2008, Biomacromolecules.

[59]  D. Puleo,et al.  A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. , 2002, Biomaterials.

[60]  R. Bareille,et al.  The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. , 2009, Biomaterials.

[61]  J. Jansen,et al.  Analysis of the osteoinductive capacity and angiogenicity of an in vitro generated extracellular matrix. , 2009, Journal of biomedical materials research. Part A.

[62]  Federica Chiellini,et al.  Polymeric Materials for Bone and Cartilage Repair , 2010 .

[63]  A. Mikos,et al.  In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. , 2009, Biomaterials.

[64]  Carl G Simon,et al.  Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. , 2008, Dental materials : official publication of the Academy of Dental Materials.

[65]  K. Matyjaszewski,et al.  Influence of cross-linker chemistry on release kinetics of PEG-co-PGA hydrogels. , 2009, Journal of biomedical materials research. Part A.

[66]  H. Burt,et al.  The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin–alginate scaffolds , 2009, Journal of tissue engineering and regenerative medicine.

[67]  W. Lu,et al.  Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors , 2003, Gene Therapy.

[68]  Y. Carvalho,et al.  Effect of calcitonin on bone regeneration in male rats: a histomorphometric analysis. , 2007, International journal of oral and maxillofacial surgery.

[69]  A. Lode,et al.  Influence of modified extracellular matrices on TI6AL4V implants on binding and release of VEGF. , 2006, Journal of biomedical materials research. Part A.

[70]  Antonios G Mikos,et al.  Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. , 2009, Tissue engineering. Part A.

[71]  H. Schliephake.  Application of bone growth factors—the potential of different carrier systems , 2009, Oral and Maxillofacial Surgery.

[72]  Jin Chang,et al.  PLGA/polymeric liposome for targeted drug and gene co-delivery. , 2010, Biomaterials.

[73]  Jaesoon Choi,et al.  In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. , 2010, Journal of biomedical materials research. Part A.

[74]  C James Kirkpatrick,et al.  Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. , 2007, Tissue engineering.

[75]  Ueon Sang Shin,et al.  Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering. , 2011, Acta biomaterialia.

[76]  Yasuhiko Tabata,et al.  In Vitro and In Vivo Release of Basic Fibroblast Growth Factor Using a Silk Fibroin Scaffold as Delivery Carrier , 2010, Journal of biomaterials science. Polymer edition.

[77]  K. So,et al.  Fabrication of nano-fibrous collagen microspheres for protein delivery and effects of photochemical crosslinking on release kinetics. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[78]  E. Korgun,et al.  Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. , 2008, Differentiation; research in biological diversity.

[79]  Dietmar W Hutmacher,et al.  Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. , 2006, Tissue engineering.

[80]  Shigeru Kobayashi,et al.  Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[81]  M. Marcacci,et al.  A conceptually new type of bio-hybrid scaffold for bone regeneration , 2011, Nanotechnology.

[82]  K. Healy,et al.  Biomimetic artificial ECMs stimulate bone regeneration. , 2006, Journal of biomedical materials research. Part A.

[83]  D. Scharnweber,et al.  Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study. , 2008, International journal of oral and maxillofacial surgery.

[84]  Bin Wu,et al.  Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loaded with synthetic BMP-2-derived peptide , 2008, Biomedical materials.

[85]  Maik Stiehler,et al.  Bioreactor systems for bone tissue engineering. , 2011, Tissue engineering. Part B, Reviews.

[86]  T. Miclau,et al.  Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? , 2007, Injury.

[87]  A. Metters,et al.  Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.

[88]  A. Mikos,et al.  Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. , 2010, Tissue engineering. Part A.

[89]  Allan S Hoffman,et al.  Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. , 2010, Biomacromolecules.

[90]  David A. Wang,et al.  Prospective evaluation of chronic pain associated with posterior autologous iliac crest bone graft harvest and its effect on postoperative outcome , 2009, Health and quality of life outcomes.

[91]  M. Wendel,et al.  Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. , 2007, Stem cells and development.

[92]  C. Ge,et al.  Use of a stringent dimerizer-regulated gene expression system for controlled BMP2 delivery. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[93]  Antonios G Mikos,et al.  Modulation of the inflammatory response for enhanced bone tissue regeneration. , 2008, Tissue engineering. Part B, Reviews.

[94]  K. Lau,et al.  Retroviral‐based gene therapy with cyclooxygenase‐2 promotes the union of bony callus tissues and accelerates fracture healing in the rat , 2008, The journal of gene medicine.

[95]  David J Mooney,et al.  Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. , 2006, Biomaterials.

[96]  K. Ishihara,et al.  Controlled drug release from multilayered phospholipid polymer hydrogel on titanium alloy surface. , 2009, Biomaterials.

[97]  A. Khademhosseini,et al.  Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. , 2011, Biomaterials.

[98]  Yasuhiko Tabata,et al.  Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. , 2006, Tissue engineering.

[99]  A. Mikos,et al.  Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor. , 2010, Acta biomaterialia.

[100]  A. Mikos,et al.  Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. , 2004, Journal of biomedical materials research. Part A.

[101]  Austin G Smith,et al.  Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. , 2005, Bone.

[102]  C. Kirker-Head,et al.  Potential applications and delivery strategies for bone morphogenetic proteins. , 2000, Advanced drug delivery reviews.

[103]  A. Matsumura,et al.  Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. , 2010, Acta biomaterialia.

[104]  Johnna S Temenoff,et al.  Engineering orthopedic tissue interfaces. , 2009, Tissue engineering. Part B, Reviews.

[105]  D W Hutmacher,et al.  The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2. , 2009, Biomaterials.

[106]  C. Tsakiroglou,et al.  Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics. , 2007, Colloids and surfaces. B, Biointerfaces.

[107]  Heungsoo Shin,et al.  Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. , 2007, Advanced drug delivery reviews.

[108]  K. Anseth,et al.  Repair of a calvarial defect with biofactor and stem cell-embedded polyethylene glycol scaffold. , 2010, Archives of facial plastic surgery.

[109]  R L Reis,et al.  Journal of Tissue Engineering and Regenerative Medicine Silk Fibroin Microparticles as Carriers for Delivery of Human Recombinant Bmps. Physical Characterization and Drug Release , 2022 .

[110]  Matthias P Lutolf,et al.  Biomimetic PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides. , 2009, Journal of biomedical materials research. Part A.

[111]  Bernard A Roos,et al.  Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. , 2006, Bone.

[112]  William V Giannobile,et al.  The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. , 2007, Biomaterials.

[113]  K. Mäder,et al.  The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[114]  J. Wiltfang,et al.  Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. , 2011, Tissue engineering. Part A.

[115]  Zhifeng Xiao,et al.  Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated with vascular endothelial growth factor. , 2011, Acta biomaterialia.

[116]  J. Goh,et al.  Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. , 2009, Journal of biomedical materials research. Part A.

[117]  Pol Maria Rommens,et al.  The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. , 2008, Biomaterials.

[118]  Y. Tabata,et al.  Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[119]  Antonios G Mikos,et al.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[120]  E. Galun,et al.  Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[121]  David J Mooney,et al.  Cell delivery mechanisms for tissue repair. , 2008, Cell stem cell.

[122]  Gorka Orive,et al.  Delivering growth factors for therapeutics. , 2008, Trends in pharmacological sciences.

[123]  U. Ripamonti,et al.  Tissue engineering: TGF-β superfamily members and delivery systems in bone regeneration , 2002, Expert Reviews in Molecular Medicine.

[124]  Eunhee Cho,et al.  A novel synthetic route for the preparation of hydrolytically degradable synthetic hydrogels. , 2009, Journal of biomedical materials research. Part A.

[125]  J. Fisher,et al.  Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. , 2011, Bone.

[126]  Chengtie Wu,et al.  Porous bioactive diopside (CaMgSi(2)O(6)) ceramic microspheres for drug delivery. , 2010, Acta biomaterialia.

[127]  N. Ferrara,et al.  Angiogenesis and bone growth. , 2000, Trends in cardiovascular medicine.

[128]  Antonios G Mikos,et al.  Mineralization of hydrogels for bone regeneration. , 2010, Tissue engineering. Part B, Reviews.

[129]  David L Kaplan,et al.  Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. , 2006, Biomaterials.

[130]  Byung-Soo Kim,et al.  Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. , 2010, Tissue engineering. Part A.

[131]  H. Lee,et al.  In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels. , 2006, Tissue engineering.

[132]  D. Schaffer,et al.  Engineering biomaterial systems to enhance viral vector gene delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[133]  J. Jansen,et al.  In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. , 2011, Acta biomaterialia.

[134]  J. Jansen,et al.  The effect of a low dose of transforming growth factor beta1 (TGF-beta1) on the early bone-healing around oral implants inserted in trabecular bone. , 2009, Biomaterials.

[135]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[136]  Ana Jaklenec,et al.  Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. , 2008, Biomaterials.

[137]  Charles A Gersbach,et al.  Virus-based gene therapy strategies for bone regeneration. , 2007, Biomaterials.

[138]  J. Jansen,et al.  Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. , 2005, Biomaterials.

[139]  C. Tonda-Turo,et al.  Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. , 2011, Journal of the mechanical behavior of biomedical materials.

[140]  S. Ahmed,et al.  Biology and clinical applications , 2004 .

[141]  M. Schulz-Siegmund,et al.  VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[142]  A. Metters,et al.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[143]  J. Fischer,et al.  Cell therapy in bone healing disorders , 2010, Orthopedic reviews.

[144]  R. Reis,et al.  Drug delivery therapies II. Strategies for delivering bone regenerating factors , 2002 .

[145]  Michael J Yaszemski,et al.  Three-dimensional porous biodegradable polymeric scaffolds fabricated with biodegradable hydrogel porogens. , 2009, Tissue engineering. Part C, Methods.

[146]  Yasuhiko Tabata,et al.  Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. , 2010, Tissue engineering. Part A.

[147]  Vasif Hasirci,et al.  Sequential growth factor delivery from complexed microspheres for bone tissue engineering. , 2008, Biomaterials.

[148]  J. Conway.  Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft. , 2010, The Orthopedic clinics of North America.

[149]  D W Hutmacher,et al.  Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. , 2005, Biomaterials.

[150]  Peter C. Johnson,et al.  Challenges in tissue engineering and regenerative medicine product commercialization: building an industry. , 2011, Tissue engineering. Part A.

[151]  Min Zhang,et al.  Toward delivery of multiple growth factors in tissue engineering. , 2010, Biomaterials.

[152]  Chaoliang He,et al.  In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[153]  Emil H Schemitsch,et al.  Growth factors and bone regeneration: how much bone can we expect? , 2011, Injury.

[154]  K. Siebenrock,et al.  Long-term cell-mediated protein release from calcium phosphate ceramics. , 2009, Journal of biomedical materials research. Part A.

[155]  Eyal Zussman,et al.  Slow-release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. , 2011, Tissue engineering. Part A.

[156]  T. Hefferan,et al.  Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration. , 2010, Tissue engineering. Part A.

[157]  J. Heckman,et al.  Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. , 1999, The Journal of bone and joint surgery. American volume.

[158]  Antonios G Mikos,et al.  Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. , 2005, Journal of biomedical materials research. Part A.

[159]  Michael J Yaszemski,et al.  Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. , 2008, Biomaterials.

[160]  F. Krummenauer,et al.  Biological activity of recombinant human growth factors released from biocompatible bone implants. , 2008, Journal of biomedical materials research. Part A.

[161]  Yourong Duan,et al.  Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels. , 2010, International journal of pharmaceutics.

[162]  Minhyung Lee,et al.  Apatite-coated collagen scaffold for bone morphogenetic protein-2 delivery. , 2011, Tissue engineering. Part A.

[163]  R. Oreffo,et al.  Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. , 2004, Tissue engineering.

[164]  H. Yoo,et al.  MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[165]  N. Dahotre,et al.  Calcium phosphate coatings for bio-implant applications: Materials, performance factors, and methodologies , 2009 .

[166]  J. Jansen,et al.  The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. , 2008, Journal of biomedical materials research. Part A.

[167]  J. Kinney,et al.  Repair of rabbit segmental defects with the thrombin peptide, TP508 , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[168]  D. Stewart,et al.  Effect of cell‐based VEGF gene therapy on healing of a segmental bone defect , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[169]  G. Pei,et al.  Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma. , 2010, Biomaterials.

[170]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[171]  Antonios G Mikos,et al.  Design of a flow perfusion bioreactor system for bone tissue-engineering applications. , 2003, Tissue engineering.

[172]  S. Soker,et al.  Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. , 2010, Biomaterials.

[173]  Christina Eckhardt,et al.  Vascular Endothelial Growth Factor Gene‐Activated Matrix (VEGF165‐GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[174]  Shu-Hua Yang,et al.  Bone induction by biomimetic PLGA-(PEG-ASP)n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[175]  Richard O C Oreffo,et al.  The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. , 2010, Biomaterials.

[176]  Benjamin M. Wu,et al.  Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. , 2009, Biomaterials.

[177]  E. Kang,et al.  Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering. , 2009, Tissue engineering. Part A.

[178]  X. Marchandise,et al.  Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. , 1999, Bone.

[179]  M. Urist.  Bone: Formation by Autoinduction , 1965, Science.

[180]  K. Na,et al.  Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). , 2007, Biomaterials.

[181]  K E Healy,et al.  A biodegradable polymer scaffold for delivery of osteotropic factors. , 2000, Biomaterials.

[182]  A G Mikos,et al.  Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[183]  J. Fisher,et al.  Nanoparticle technology in bone tissue engineering , 2007, Journal of drug targeting.

[184]  Heung Jae Chun,et al.  Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[185]  J. Jansen,et al.  Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. , 2009, Journal of biomedical materials research. Part A.

[186]  F. Singer,et al.  Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis. , 1981, The Journal of clinical investigation.

[187]  Gabriela A Silva,et al.  Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.

[188]  Antonios G Mikos,et al.  Harnessing and modulating inflammation in strategies for bone regeneration. , 2011, Tissue engineering. Part B, Reviews.

[189]  T. Hefferan,et al.  Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds. , 2009, Tissue engineering. Part A.

[190]  Takaaki Tanaka,et al.  Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. , 2006, Biomaterials.

[191]  Sung Min Kang,et al.  Osteoconductive conjugation of bone morphogenetic protein-2 onto titanium/titanium oxide surfaces coated with non-biofouling poly(poly(ethylene glycol) methacrylate). , 2010, Colloids and surfaces. B, Biointerfaces.

[192]  Fa-Ming Chen,et al.  In vitro cellular responses to scaffolds containing two microencapulated growth factors. , 2009, Biomaterials.

[193]  Yinghong Zhou,et al.  In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for bone morphogenetic protein-7 gene delivery. , 2011, Tissue engineering. Part C, Methods.

[194]  J. van den Dolder,et al.  Bone formation in CaP-coated and noncoated titanium fiber mesh. , 2003, Journal of biomedical materials research. Part A.

[195]  D. Kaplan,et al.  Bone morphogenetic protein-2 binds as multilayers to a collagen delivery matrix: an equilibrium thermodynamic analysis. , 2006, Biomacromolecules.

[196]  Ling Li,et al.  Prospective study of iliac crest bone graft harvest site pain and morbidity. , 2009, The spine journal : official journal of the North American Spine Society.

[197]  Antonios G Mikos,et al.  Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects. , 2010, Tissue engineering. Part A.

[198]  Sang Hoon Lee,et al.  Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. , 2007, Biomaterials.

[199]  H. Sung,et al.  Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. , 2009, International journal of pharmaceutics.

[200]  J. Herzenberg,et al.  Bone Graft Harvest Using a New Intramedullary System , 2008, Clinical orthopaedics and related research.

[201]  Antonios G Mikos,et al.  In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[202]  Jennifer Patterson,et al.  Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. , 2010, Biomaterials.

[203]  S. Bhang,et al.  Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. , 2008, Biochemical and biophysical research communications.

[204]  P H Krebsbach,et al.  Localized viral vector delivery to enhance in situ regenerative gene therapy , 2007, Gene Therapy.

[205]  Pieter Buma,et al.  Anisotropic Porous Biodegradable Scaffolds for Musculoskeletal Tissue Engineering , 2009, Materials.

[206]  J. Miyazaki,et al.  Simple strategy for bone regeneration with a BMP-2/7 gene expression cassette vector. , 2009, Biochemical and biophysical research communications.

[207]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[208]  Jian Dong,et al.  The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. , 2010, Biomaterials.

[209]  Thomas J Webster,et al.  Ceramic/polymer nanocomposites with tunable drug delivery capability at specific disease sites. , 2009, Journal of biomedical materials research. Part A.

[210]  R. Reis,et al.  Silk fibroin microparticles as carriers for delivery of human recombinant bone morphogenetic protein-2: in vitro and in vivo bioactivity. , 2010, Tissue engineering. Part C, Methods.

[211]  Antonios G Mikos,et al.  In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. , 2003, Biomaterials.

[212]  Maria Luisa Brandi,et al.  Vascular Biology and the Skeleton , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[213]  Henning Schliephake,et al.  Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an experimental study in rats. , 2008, Biomaterials.

[214]  Jeffrey C. Wang,et al.  Comparison of Lentiviral and Adenoviral Gene Therapy for Spinal Fusion in Rats , 2008, Spine.

[215]  Aldo R Boccaccini,et al.  The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds. , 2011, Biomaterials.

[216]  Hani Awad,et al.  Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. , 2009, Tissue engineering. Part B, Reviews.

[217]  H. Seeherman,et al.  Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. , 2005, Cytokine & growth factor reviews.

[218]  Kristi S. Anseth,et al.  PEG Hydrogels for the Controlled Release of Biomolecules in Regenerative Medicine , 2009, Pharmaceutical Research.

[219]  Robert E Guldberg,et al.  Sustained release of BMP-2 in a lipid-based microtube vehicle. , 2009, Acta biomaterialia.

[220]  J. van den Dolder,et al.  Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-beta 1 loaded gelatin microparticles. , 2008, Biomaterials.

[221]  T A Einhorn,et al.  Growth Factor Regulation of Fracture Repair , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[222]  A. Caplan.  New era of cell-based orthopedic therapies. , 2009, Tissue engineering. Part B, Reviews.

[223]  David J Mooney,et al.  VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[224]  Eleftherios Tsiridis,et al.  Current concepts of molecular aspects of bone healing. , 2005, Injury.

[225]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[226]  A. Turner,et al.  In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. , 2006, The spine journal : official journal of the North American Spine Society.

[227]  Hasan Uludağ,et al.  Nanoparticulate Systems for Growth Factor Delivery , 2009, Pharmaceutical Research.

[228]  Christian Koch,et al.  A strategy to establish a gene-activated matrix on titanium using gene vectors protected in a polylactide coating. , 2011, Biomaterials.

[229]  Y. Tabata,et al.  Bone regeneration using titanium nonwoven fabrics combined with fgf-2 release from gelatin hydrogel microspheres in rabbit skull defects. , 2008, Tissue engineering. Part A.

[230]  Bochu Wang,et al.  Factors affecting protein release from microcapsule prepared by liposome in alginate. , 2005, Colloids and surfaces. B, Biointerfaces.

[231]  G. Pelled,et al.  Ultrasound-based nonviral gene delivery induces bone formation in vivo , 2008, Gene Therapy.

[232]  David Dean,et al.  Bone formation in transforming growth factor beta-1-coated porous poly(propylene fumarate) scaffolds. , 2002, Journal of biomedical materials research.

[233]  M. Leigheb,et al.  Effect of different growth factors on human osteoblasts activities: a possible application in bone regeneration for tissue engineering. , 2007, Biomolecular engineering.

[234]  J. Huard,et al.  Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[235]  J. Jansen,et al.  Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration. , 2010, Biomacromolecules.

[236]  Günter Finkenzeller,et al.  Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. , 2011, Tissue engineering. Part A.

[237]  Raul Machado,et al.  Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[238]  Helen H. Lu,et al.  Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. , 2008, Journal of biomedical materials research. Part A.

[239]  Michael J Yaszemski,et al.  Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[240]  M. Tabrizian,et al.  A hybrid rhOP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis , 2010, Growth factors.

[241]  M. Liebergall,et al.  Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. , 2006, Tissue engineering.

[242]  Cato T Laurencin,et al.  Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy–cell transplantation approach , 2008, Proceedings of the National Academy of Sciences.

[243]  C. Chung,et al.  Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules. , 2006, Journal of biomedical materials research. Part A.

[244]  T. Nishihara,et al.  Heparin inhibits BMP‐2 osteogenic bioactivity by binding to both BMP‐2 and BMP receptor , 2008, Journal of cellular physiology.

[245]  E. Jabbari,et al.  Effect of encapsulation or grafting on release kinetics of recombinant human bone morphogenetic protein‐2 from self‐assembled poly(lactide‐co‐glycolide ethylene oxide fumarate) nanoparticles , 2010, Microscopy research and technique.

[246]  T. Lenarz,et al.  Amino-modified silica surfaces efficiently immobilize bone morphogenetic protein 2 (BMP2) for medical purposes. , 2011, Acta biomaterialia.

[247]  T. Webster,et al.  Molecular plasma deposited peptides on anodized nanotubular titanium: an osteoblast density study. , 2011, Journal of biomedical materials research. Part A.

[248]  J. Mano.  Stimuli‐Responsive Polymeric Systems for Biomedical Applications , 2008 .

[249]  K. Shakesheff,et al.  The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. , 2008, Biomaterials.

[250]  David J Mooney,et al.  Quantitative assessment of scaffold and growth factor‐mediated repair of critically sized bone defects , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[251]  H. Seeherman,et al.  Protein-based tissue engineering in bone and cartilage repair. , 2004, Current Opinion in Biotechnology.

[252]  M. Farach-Carson,et al.  Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. , 2005, Tissue engineering.

[253]  Y. Tabata,et al.  Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits. , 2002, Biomaterials.

[254]  J Amédée,et al.  Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. , 2009, Trends in biotechnology.

[255]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[256]  David J Mooney,et al.  An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. , 2011, Biomaterials.

[257]  J. Hubbell,et al.  Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. , 2009, Biomaterials.

[258]  A. Ammann,et al.  An intraosseous device for studies of bone-healing. The effect of transforming growth-factor beta. , 1992, The Journal of bone and joint surgery. American volume.

[259]  L. Schmidt‐Mende,et al.  ZnO - nanostructures, defects, and devices , 2007 .

[260]  K. Shiba,et al.  Directional BMP-2 for functionalization of titanium surfaces. , 2009, Biomaterials.

[261]  Junfeng Zhang,et al.  Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. , 2011, Biomaterials.

[262]  Xuebin B. Yang,et al.  Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. , 2004, Tissue engineering.

[263]  J. Jansen,et al.  Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[264]  Antonios G Mikos,et al.  Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. , 2008, Acta biomaterialia.

[265]  E. Schwarz,et al.  Review: gene- and stem cell-based therapeutics for bone regeneration and repair. , 2007, Tissue engineering.

[266]  Benjamin M Wu,et al.  High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. , 2011, Tissue engineering. Part A.

[267]  Qixin Zheng,et al.  Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[268]  Aaron Schindeler,et al.  Bone remodeling during fracture repair: The cellular picture. , 2008, Seminars in cell & developmental biology.

[269]  Bai Yang,et al.  In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds , 2007, Biomedical engineering online.

[270]  J. Jansen,et al.  Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. , 2007, Osteoarthritis and cartilage.

[271]  P. Giannoudis,et al.  Molecular aspects of fracture healing: which are the important molecules? , 2007, Injury.

[272]  J A Planell,et al.  Calcium phosphate cements as bone drug delivery systems: a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[273]  M. Wendel,et al.  Cell-derived matrix enhances osteogenic properties of hydroxyapatite. , 2011, Tissue engineering. Part A.

[274]  V. Hasırcı,et al.  Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. , 2009, Journal of biomedical materials research. Part A.

[275]  A. Mikos,et al.  Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. , 2004, Biomaterials.

[276]  Jason A Burdick,et al.  Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[277]  Eben Alsberg,et al.  Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[278]  Timo Jämsä,et al.  Adenoviral VEGF‐A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues , 2003, The journal of gene medicine.

[279]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[280]  M. Kassem,et al.  Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. , 2010, Bone.

[281]  Jong-Ho Lee,et al.  Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[282]  B. Melsen,et al.  Human recombinant transforming growth factor-beta 1 in healing of calvarial bone defects. , 1996, The Journal of craniofacial surgery.

[283]  S. Bronson,et al.  Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage , 2009, Journal of cellular biochemistry.

[284]  A. Dierich,et al.  Active multilayered capsules for in vivo bone formation , 2010, Proceedings of the National Academy of Sciences.

[285]  C. Plank,et al.  Future of local bone regeneration - Protein versus gene therapy. , 2011, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[286]  Paul H Wooley,et al.  Promotion of osteogenesis in tissue‐engineered bone by pre‐seeding endothelial progenitor cells‐derived endothelial cells , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[287]  K. Lau,et al.  LMP-1 Retroviral Gene Therapy Influences Osteoblast Differentiation and Fracture Repair: A Preliminary Study , 2008, Calcified Tissue International.

[288]  Marc Long,et al.  Bone Graft Substitutes , 2003 .

[289]  Teruyuki Nagamune,et al.  Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2. , 2009, Journal of bioscience and bioengineering.

[290]  Jeffrey C. Wang,et al.  Comparison of Human Mesenchymal Stem Cells Derived From Adipose Tissue and Bone Marrow for Ex Vivo Gene Therapy in Rat Spinal Fusion Model , 2008, Spine.

[291]  D. Scharnweber,et al.  Immobilization of oligonucleotides on titanium based materials by partial incorporation in anodic oxide layers. , 2009, Biomaterials.